Skip to main content
. 2020 Apr 24;18:1074–1083. doi: 10.1016/j.csbj.2020.04.014

Table 1.

Major puromycin derivatives.

Compound Description Uses
Nucleoside substitutions
5′ Fluorophore-dC-puromycin Cy3, Cy5, or fluorescein attached via deoxycytidine linker Imaging protein synthesis in cultured cells [23]; In vitro C-terminal labeling of full-length proteins [24]
5′ Biotin-dC-puromycin Biotin attached via deoxycytidine linker Labeling newly synthesized proteins under cell free conditions for subsequent affinity purification and proteomic analysis [25], [26]
5′ alkyne/azide puromycin (5Y/5Z/5N/5T) Alkyne/azide substitution of the 5′ hydroxyl group Labeling newly synthesized proteins in cultured cells for visualization or affinity purification using click chemistry cycloaddition of fluorophore/biotin [19]
Amino acid substitutions
O-propargyl-puromycin (OPP) Alkyne substitution of the O-methyl-phenyl ring Labeling newly synthesized proteins in cultured cells, tissues and whole animals for visualization or affinity purification using click chemistry cycloaddition of fluorophore/biotin [8], [27]
Photocleavable N-blocked (NVOC/DEACM) puromycin Photocleavable group attached to the free amino terminus Labeling newly synthesized proteins in cultured cells with improved spatiotemporal resolution using laser excitation [17], [18]
Enzyme labile N-blocked puromycin (PhAc-puro) Enzyme labile phenylacetyl group attached to the free amino terminus Selective labeling of newly synthesized proteins in cultured cells engineered to express an E. coli enzyme [28]
N-blocked biotin puromycin (3P) Biotin attached to the free amino terminus via double Jeffamine linker Affinity purification of ribosomes under cell free conditions (without puromycylation) [16]